Edition:
India

Bavarian Nordic A/S (BAVA.CO)

BAVA.CO on Copenhagen Stock Exchange

150.50DKK
14 Jun 2019
Change (% chg)

kr.0.90 (+0.60%)
Prev Close
kr.149.60
Open
kr.150.10
Day's High
kr.151.30
Day's Low
kr.147.00
Volume
79,235
Avg. Vol
147,707
52-wk High
kr.209.80
52-wk Low
kr.117.75

About

Bavarian Nordic A/S is a Denmark-based biotechnology company engaged in the development, production and marketing of vaccines for the treatment of cancer and infectious diseases. The Company’s drug pipeline comprises two areas: Cancer Immunotherapy and Infectious Disease. The Cancer Immunotherapy pipeline is focused on: prostate... (more)

Overall

Beta: 1.27
Market Cap(Mil.): kr.9,290.57
Shares Outstanding(Mil.): 31.98
Dividend: --
Yield (%): --

Financials

  BAVA.CO Industry Sector
P/E (TTM): 40.08 29.30 32.55
EPS (TTM): 7.25 -- --
ROI: 11.17 14.23 13.82
ROE: 11.48 15.46 15.24

BRIEF-Bavarian Nordic REPORTS Positive Result From Phase 2 Trial Evaluating BN-Brachyury In Chordoma

* REPORTED ON WEDNESDAY POSITIVE RESULT FROM ONGOING PHASE 2 TRIAL EVALUATING BN-BRACHYURY IN CHORDOMA

06 Jun 2019

Earnings vs. Estimates